Lung Cancer Trial, Recruiting NCT05778708 Sponsor: The University of Hong Kong Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT05778708
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with stage IIIB or IV non-small cell lung cancer, confirmed by a tissue test, and have not been diagnosed with any other cancer in the past year
  • People whose general physical functioning is rated between 0 and 2 on a standard scale used by doctors to measure how much a health condition affects daily activities (confirm with trial site)
  • People who have experienced sleep problems, anxiety, depression, and tiredness in the past week, each rated at least 1 out of 10 on a symptom scale
  • People who are able to communicate in Cantonese, Mandarin, or English
  • People who are conscious and mentally alert

Who may not be able to join:

  • People who have a condition that makes exercise difficult or unsafe, such as an active neurological disorder or a recent heart attack
  • People who are currently taking part in any other exercise or mind-body programs or classes
  • People who are already doing regular exercise, meaning at least 150 minutes of moderate-intensity physical activity each week

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chia-Chin Lin, PhD,FAAN,RN, The University of Hong Kong

Phone: 39176633

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 March 2023
Est. completion
1 February 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Change from Baseline Emotional symptom cluster at 8 weeks; Change from Baseline Emotional symptom cluster at 16 weeks; Change from Baseline Emotional symptom cluster at 28 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov